BrainStorm Cell Therapeutics
BCLI
#10863
Rank
โ‚น0.82 B
Marketcap
โ‚น75.21
Share price
-1.25%
Change (1 day)
43.27%
Change (1 year)

Earnings for BrainStorm Cell Therapeutics (BCLI)

Earnings in 2026 (TTM): -โ‚น0.86 Billion

According to BrainStorm Cell Therapeutics's latest financial reports the company's current earnings are N/A. In 2025 the company made an earning of -โ‚น0.99 Billion, an increase over its 2024 earnings that were of -โ‚น1.11 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for BrainStorm Cell Therapeutics from 2003 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -โ‚น0.86 Billion-13.04%
2025 -โ‚น0.99 Billion-11.32%
2024 -โ‚น1.11 Billion-32.39%
2023 -โ‚น1.64 Billion-29.18%
2022 -โ‚น2.32 Billion-0.74%
2021 -โ‚น2.33 Billion-23.12%
2020 -โ‚น3.03 Billion36.8%
2019 -โ‚น2.22 Billion66.71%
2018 -โ‚น1.33 Billion181.66%
2017 -โ‚น0.48 Billion-0.6%
2016 -โ‚น0.48 Billion-41.31%
2015 -โ‚น0.81 Billion-8.22%
2014 -โ‚น0.89 Billion89.74%
2013 -โ‚น0.47 Billion42.27%
2012 -โ‚น0.33 Billion-12.45%
2011 -โ‚น0.38 Billion63.04%
2010 -โ‚น0.23 Billion35.52%
2009 -โ‚น0.17 Billion-48.99%
2008 -โ‚น0.34 Billion-44.39%
2007 -โ‚น0.6 Billion
2005 -โ‚น0.31 Billion-91.44%
2004 -โ‚น3.6 Billion94007.62%
2003 -โ‚น3.83 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Biogen
BIIB
โ‚น154.50 B-17,059.25%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
โ‚น1.021 T-112,200.31%๐Ÿ‡บ๐Ÿ‡ธ USA
Seagen
SGEN
-โ‚น75.27 Billion 8,160.98%๐Ÿ‡บ๐Ÿ‡ธ USA
Cytokinetics
CYTK
-โ‚น78.98 Billion 8,568.86%๐Ÿ‡บ๐Ÿ‡ธ USA
Agenus
AGEN
โ‚น11.38 B-1,350.16%๐Ÿ‡บ๐Ÿ‡ธ USA
Acceleron Pharma
XLRN
-โ‚น24.33 Billion 2,569.69%๐Ÿ‡บ๐Ÿ‡ธ USA